Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,574.50 +0.94%
EUR-USD 1.2511 -0.1714%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 90.77 +0.12%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%

Sanofi Is Studying Ophthalmology Acquisitions, Les Echos Says

Sanofi-Aventis SA plans to spend 1 billion euros over the next three years on acquisitions in ophthalmology, Les Echos reported, without saying where it got the information.

The company is currently studying “closely” four potential purchases, three of which are in the U.S. and the other in Israel, the French newspaper said. It didn’t name the companies.

To contact the editor responsible for this story: Steve Rhinds at srhinds@bloomberg.net

Sponsored Links